YAP1 and neuroblastoma: While our studies have identified YAP’s role in suppressing HRK to promote neuroblastoma tumor growth and resistance to chemotherapy and targeted therapy in the in situ tumor environment [51], further investigations in our laboratory are underway to understand the actual mechanism for how YAP regulates HRK and other tumor suppressor genes to inhibit their expression and activity.